Form 4: MicroVision Director Carlile's RSU Vesting

MicroVision Director Robert Paul Carlile acquired 22,007 shares of common stock through the vesting of restricted stock units.

Summary

• Director Robert Paul Carlile acquired 22,007 shares of MicroVision, Inc. common stock.
• The acquisition resulted from the vesting of restricted stock units (RSUs) at a price of $0.00 per share.
• Following this transaction, Carlile beneficially owns 350,799 shares of common stock.
• The RSUs were granted on June 6, 2025, and are scheduled to vest in four equal quarterly installments.
• Full vesting is expected on the earlier of the first anniversary of the grant date or the day prior to the Issuer's 2026 Annual Meeting of Stockholders, contingent on continued director service.
• A previous Form 4 filed on June 6, 2025, incorrectly reported the total RSUs granted as 87,462 instead of the correct amount of 88,028 RSUs. This filing's vesting calculation is based on the corrected amount.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, reflecting routine director compensation and increased insider ownership, with a minor administrative correction to a prior filing.

Positives

• The vesting of restricted stock units indicates continued compensation and retention of a key director.
• The director's increased direct ownership aligns their interests with shareholders.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, such as RSU vestings, are common compensation mechanisms in the technology sector, particularly for directors, aligning their long-term interests with company performance and shareholder value.

Comparison to Industry Standards

• StockSavvy.ai observes that RSU vesting schedules, often tied to continued service and multi-year periods, are standard practice across publicly traded companies, including peers in the LiDAR and display technology space like Luminar Technologies (LAZR) or Aeva Technologies (AEVA), to retain key talent and incentivize long-term commitment.
• The $0.00 exercise price for vested RSUs is also standard, as these are typically granted as part of compensation rather than purchased.

Stakeholder Impact

• Shareholders: Increased alignment of director's interests with shareholders due to increased direct ownership.
• Employees: No direct impact on general employees.
• Customers: No direct impact on customers.
• Suppliers: No direct impact on suppliers.
• Creditors: No direct impact on creditors.

Next Steps

• Continued vesting of the remaining RSUs in equal quarterly installments.
• Continued service of Robert Paul Carlile as a director through each vesting date.
• The Issuer's 2026 Annual Meeting of Stockholders, which is a condition for full RSU vesting.

Key Dates

Recommendation

This Form 4 filing reports a routine insider transaction (RSU vesting) and a minor correction to a previous filing. It does not contain information that would fundamentally alter the investment thesis for MicroVision, Inc. While it shows continued director alignment, it's not a catalyst for a 'buy' or 'sell' recommendation. Therefore, a 'hold' recommendation is appropriate as investors should rely on broader company fundamentals and strategic developments.

Keywords

MicroVision, MVIS, Robert Paul Carlile, Director, SEC Form 4, Restricted Stock Units, RSU vesting, Insider Transaction, Common Stock, Beneficial Ownership